Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasis - 15/02/15
, Elaine Hamarstrom, PhD a, Patrick Sluka, MPH a, Christine M. Presta a, Jennifer S. Thompson, MS a, Robert S. Kirsner, MD, PhD bAbstract |
Background |
The Performance Improvement (PI) CME format improves physician performance in other specialties but data are lacking in dermatology.
Objective |
We sought to assess the impact of a PI CME activity on physician practice patterns for patients with psoriasis, which was developed, implemented, and evaluated by the American Academy of Dermatology (AAD), in part to assist dermatologists in fulfilling Part IV of their Maintenance of Certification requirements.
Methods |
In this PI CME activity, participants: (1) self-audited patient charts, which met inclusion criteria in stage A, and reflected on their results, benchmarked against peers; (2) reviewed educational materials in stage B and developed an improvement plan; and (3) self-audited a different set of patient charts following the plan's implementation. Aggregate stage A and C data were analyzed using χ2 tests.
Results |
We found a statistically significant improvement in the advisement of patients with psoriasis regarding their increased risk for cardiovascular disease, to contact their primary care provider for cardiovascular risk assessment, and in shared decision making regarding the treatment plan. We also found an overall statistically significant improvement in history taking per the guidelines.
Limitations |
Learner chart selection bias, self-reporting of chart data, and lack of a control group are limitations.
Conclusions |
The AAD psoriasis PI CME activity demonstrated significantly improved dermatologists' documentation of patient's history, counseling of patients for lifestyle behaviors, and shared decision making.
Le texte complet de cet article est disponible en PDF.Key words : comorbidities, counseling patients, evidence-based medicine, Maintenance of Certification, part IV, patient outcome, Performance Improvement CME, physician performance, practice gaps, psoriasis, psoriasis guidelines, shared decision making
Abbreviations used : AAD, AMA, PI
Plan
| The development of this Performance Improvement CME activity was supported by educational grants from Abbott (now AbbVie), Amgen, and Centocor Ortho Biotech Inc (now Janssen Biotech Inc) in strict compliance with the Accreditation Council for CME Standards for Commercial Support of CME. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 72 - N° 3
P. 516-523 - mars 2015 Retour au numéro
Article précédent
- CD30+ cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes
- Joan Guitart, Maria Estela Martinez-Escala, Janyana M.D. Deonizio, Pedram Gerami, Marshall E. Kadin
- A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons
- Deanna G. Brown, Eric C. Wilkerson, W. Elliot Love
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?